The effect of pharmacologic pupillary dilatation on anterior segment parameters in patients with exfoliation syndrome

Purpose: The purpose of this study was to evaluate the effect of pharmacologic pupillary dilatation on anterior chamber depth (ACD) and anterior chamber angle (ACA) in eyes with exfoliation syndrome (XFS). Methods: Thirty-six eyes of 36 patients with XFS were evaluated with slit-lamp examination, Go...

Full description

Bibliographic Details
Main Authors: Mehmet Cem Mocan, Saim Ustunel, Ozlem Dikmetas, Banu Bozkurt, Murat Irkec
Format: Article
Language:English
Published: Elsevier 2014-01-01
Series:Journal of Optometry
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1888429613000307
_version_ 1818551708951773184
author Mehmet Cem Mocan
Saim Ustunel
Ozlem Dikmetas
Banu Bozkurt
Murat Irkec
author_facet Mehmet Cem Mocan
Saim Ustunel
Ozlem Dikmetas
Banu Bozkurt
Murat Irkec
author_sort Mehmet Cem Mocan
collection DOAJ
description Purpose: The purpose of this study was to evaluate the effect of pharmacologic pupillary dilatation on anterior chamber depth (ACD) and anterior chamber angle (ACA) in eyes with exfoliation syndrome (XFS). Methods: Thirty-six eyes of 36 patients with XFS were evaluated with slit-lamp examination, Goldmann applanation tonometry and ultrasound biomicroscopy (UBM) under standard light conditions. Primary outcome parameters were defined as the change in ACD and ACA measured before and 40 min after instillation of a single drop of either 1% cyclopentolate (Group I; n = 12), 2.5% phenylephrine (Group II; n = 12) or 1% tropicamide (Group III; n = 12). Change in intraocular pressure (IOP) during the same time interval was included as a secondary outcome measure. Results: The average predilatation ACD, ACA and IOP values in the study subjects were 2.54 ± 0.40 mm, 27.9 ± 6.3° and 14.9 ± 3.1 mmHg, respectively. There were no significant differences in the mean age (p = 0.461), the female/male ratio (p = 0.232), baseline ACD (p = 0.841), ACA (p = 0.761) or IOP (p = 0.070) within the three groups. Differences in dilation induced changes in ACD (p = 0.108), ACA (p = 0.636) and IOP (p = 0.160) between the three groups were not statistically significant. Conclusion: Pupillary dilatation with a single drop of 1.0% cyclopentolate, 2.5% phenylephrine or 1% tropicamide is not associated with shallowing of the anterior chamber or narrowing of the ACA in patients with XFS who present with open angles.
first_indexed 2024-12-12T09:03:30Z
format Article
id doaj.art-27e87e156ed04795a4c790b17291a8a8
institution Directory Open Access Journal
issn 1888-4296
language English
last_indexed 2024-12-12T09:03:30Z
publishDate 2014-01-01
publisher Elsevier
record_format Article
series Journal of Optometry
spelling doaj.art-27e87e156ed04795a4c790b17291a8a82022-12-22T00:29:45ZengElsevierJournal of Optometry1888-42962014-01-0171515610.1016/j.optom.2013.05.001The effect of pharmacologic pupillary dilatation on anterior segment parameters in patients with exfoliation syndromeMehmet Cem Mocan0Saim Ustunel1Ozlem Dikmetas2Banu Bozkurt3Murat Irkec4Hacettepe University School of Medicine, Department of Ophthalmology, Ankara, TurkeyHacettepe University School of Medicine, Department of Ophthalmology, Ankara, TurkeyHacettepe University School of Medicine, Department of Ophthalmology, Ankara, TurkeySelcuk University Faculty of Medicine, Department of Ophthalmology, Konya, TurkeyHacettepe University School of Medicine, Department of Ophthalmology, Ankara, TurkeyPurpose: The purpose of this study was to evaluate the effect of pharmacologic pupillary dilatation on anterior chamber depth (ACD) and anterior chamber angle (ACA) in eyes with exfoliation syndrome (XFS). Methods: Thirty-six eyes of 36 patients with XFS were evaluated with slit-lamp examination, Goldmann applanation tonometry and ultrasound biomicroscopy (UBM) under standard light conditions. Primary outcome parameters were defined as the change in ACD and ACA measured before and 40 min after instillation of a single drop of either 1% cyclopentolate (Group I; n = 12), 2.5% phenylephrine (Group II; n = 12) or 1% tropicamide (Group III; n = 12). Change in intraocular pressure (IOP) during the same time interval was included as a secondary outcome measure. Results: The average predilatation ACD, ACA and IOP values in the study subjects were 2.54 ± 0.40 mm, 27.9 ± 6.3° and 14.9 ± 3.1 mmHg, respectively. There were no significant differences in the mean age (p = 0.461), the female/male ratio (p = 0.232), baseline ACD (p = 0.841), ACA (p = 0.761) or IOP (p = 0.070) within the three groups. Differences in dilation induced changes in ACD (p = 0.108), ACA (p = 0.636) and IOP (p = 0.160) between the three groups were not statistically significant. Conclusion: Pupillary dilatation with a single drop of 1.0% cyclopentolate, 2.5% phenylephrine or 1% tropicamide is not associated with shallowing of the anterior chamber or narrowing of the ACA in patients with XFS who present with open angles.http://www.sciencedirect.com/science/article/pii/S1888429613000307Exfoliation syndromeAnterior chamber depthAnterior chamber angleUltrasound biomicroscopyPupillary dilatation
spellingShingle Mehmet Cem Mocan
Saim Ustunel
Ozlem Dikmetas
Banu Bozkurt
Murat Irkec
The effect of pharmacologic pupillary dilatation on anterior segment parameters in patients with exfoliation syndrome
Journal of Optometry
Exfoliation syndrome
Anterior chamber depth
Anterior chamber angle
Ultrasound biomicroscopy
Pupillary dilatation
title The effect of pharmacologic pupillary dilatation on anterior segment parameters in patients with exfoliation syndrome
title_full The effect of pharmacologic pupillary dilatation on anterior segment parameters in patients with exfoliation syndrome
title_fullStr The effect of pharmacologic pupillary dilatation on anterior segment parameters in patients with exfoliation syndrome
title_full_unstemmed The effect of pharmacologic pupillary dilatation on anterior segment parameters in patients with exfoliation syndrome
title_short The effect of pharmacologic pupillary dilatation on anterior segment parameters in patients with exfoliation syndrome
title_sort effect of pharmacologic pupillary dilatation on anterior segment parameters in patients with exfoliation syndrome
topic Exfoliation syndrome
Anterior chamber depth
Anterior chamber angle
Ultrasound biomicroscopy
Pupillary dilatation
url http://www.sciencedirect.com/science/article/pii/S1888429613000307
work_keys_str_mv AT mehmetcemmocan theeffectofpharmacologicpupillarydilatationonanteriorsegmentparametersinpatientswithexfoliationsyndrome
AT saimustunel theeffectofpharmacologicpupillarydilatationonanteriorsegmentparametersinpatientswithexfoliationsyndrome
AT ozlemdikmetas theeffectofpharmacologicpupillarydilatationonanteriorsegmentparametersinpatientswithexfoliationsyndrome
AT banubozkurt theeffectofpharmacologicpupillarydilatationonanteriorsegmentparametersinpatientswithexfoliationsyndrome
AT muratirkec theeffectofpharmacologicpupillarydilatationonanteriorsegmentparametersinpatientswithexfoliationsyndrome
AT mehmetcemmocan effectofpharmacologicpupillarydilatationonanteriorsegmentparametersinpatientswithexfoliationsyndrome
AT saimustunel effectofpharmacologicpupillarydilatationonanteriorsegmentparametersinpatientswithexfoliationsyndrome
AT ozlemdikmetas effectofpharmacologicpupillarydilatationonanteriorsegmentparametersinpatientswithexfoliationsyndrome
AT banubozkurt effectofpharmacologicpupillarydilatationonanteriorsegmentparametersinpatientswithexfoliationsyndrome
AT muratirkec effectofpharmacologicpupillarydilatationonanteriorsegmentparametersinpatientswithexfoliationsyndrome